CBD Life Sciences, Inc. (CBDL) Announces Retail Store Updates
CBD Life Sciences (OTC PINK:CBDL) announces its second retail store grand opening on June 12 in Scottsdale, AZ. CEO Lisa Nelson highlights the company’s ongoing expansion, including plans for a third location in Sedona and potential fourth on the Las Vegas Strip. The firm is capitalizing on Arizona's new recreational cannabis market, allowing it to offer premium products to a wider audience. Following recent approval for Amazon sales, CBD Life Sciences is optimistic about growth and revenue for the remainder of 2021.
- Grand opening of second retail location in Scottsdale, AZ scheduled for June 12.
- Plans for third location in Sedona and potential fourth on the Las Vegas Strip.
- Recent approval to sell on Amazon enhances market reach.
- Opportunity to offer products in Arizona's recreational cannabis market.
- None.
SCOTTSDALE, AZ / ACCESSWIRE / May 19, 2021 / Today, CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson is proud to provide the shareholders with retail store updates.
CBD Life Sciences Inc. is having a grand opening for its second retail location on June 12. This storefront will be located in Scottsdale, AZ at 10953 North Frank Lloyd Wright Blvd Unit 108. President & CEO Lisa Nelson states, "As the company continues to expand significantly, we will be updating the shareholders with as much news as we possibly can as time goes on." The company is currently awaiting approval for a third storefront in Sedona, AZ while also exploring locations on the Las Vegas strip for a fourth storefront, which is fantastic news as far as expansion goes! President & CEO Lisa Nelson also stated, "We have been working extremely hard this year and I couldn't be any happier with the outcome!" With the recent approval of Amazon and the future storefronts, the rest of 2021 looks very promising as far as revenue and growth go.
Why shop LBC Bioscience Inc?
- From employment to sourcing, we get everything done in the country we operate from to support the people & businesses.
- Given that hemp is a natural phytoremediation, it inevitably absorbs toxins such as heavy metals, pesticides, herbicides from the soil & air it's planted in. We take great measures to ensure the surrounding environment is tested & monitored closely to ensure the utmost safety.
- Although all steps to our practice are crucial, one of the most essential parts of having a quality extract starts from the seed. A seed with good genetics produces a more potent cannabinoid & terpene profile.
- We extract using the most effective parts of the plant, the buds & flowers, to maximize the full potential of hemp. Whole-Plant, also known as Entourage Effect, is when cannabinoids, terpenes, & flavonoids work together rather than just CBD alone.
CBD Life Sciences Inc. has already identified several potential cultivation sites with the Arizona PROP 207 approved and is aggressively pursuing amazing new opportunities in Arizona's new recreational cannabis market. This new law gives CBD Life Sciences Inc. the capability of offering licensed retailers CBD Life Sciences Inc. premium cannabis products which are then made available for sale to 1000's of future recreational cannabis customers in addition to current cannabis sales to existing medical-use dispensaries in Arizona.
The number of benefits CBD has is tremendous! These benefits include help with behavioral/neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC BIOSCIENCE INC. ONLINE STORE
LBC BIOSCIENCE'S Online Emporium
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
- Large Selection of Products (over 50 items and growing)
100% USA Made Products "organic & kosher."- All Products are THC-FREE (they contain
0.00% THC) - Weekly Deals (new deals every week)
20% off on all products using code "LBC20."
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/648072/CBD-Life-Sciences-Inc-CBDL-Announces-Retail-Store-Updates
FAQ
What is the significance of CBD Life Sciences' new retail opening on June 12?
How many retail locations does CBD Life Sciences plan to open in 2021?
What are the growth expectations for CBD Life Sciences in 2021?
What products will be available at CBD Life Sciences' new stores?
How does Arizona's new recreational cannabis law impact CBD Life Sciences?
